: Covers emerging areas such as the gastrointestinal and hepatic manifestations of COVID-19 , and a dedicated section on neoplasia involving multiple organs .
: Features more than 1,100 full-color illustrations and quick-reference algorithms to streamline clinical decision-making.
This edition welcomes a new senior editorial team—Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox—and introduces significant updates to reflect the rapidly evolving landscape of GI and hepatology. s gastrointestinal and liver disease 12th edition hot
Review: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease 12th Edition
Sleisenger and Fordtran's Gastrointestinal and Liver Disease : Covers emerging areas such as the gastrointestinal
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more shop.elsevier.comhttps://shop.elsevier.com
For over 50 years, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease has been the gold standard for medical professionals in the field. The newly released continues this legacy, offering a comprehensive, two-volume masterwork that covers the latest advancements in pathophysiology, diagnosis, and patient management. Key Features of the 12th Edition Raymond T
: Includes expanded discussions on using Artificial Intelligence (AI) in endoscopy for improved cancer detection.
: Provides the latest evidence-based guidance on metabolic dysfunction-associated steatotic liver disease ( MASLD ), eosinophilic disorders, and new treatments for viral hepatitis and inflammatory bowel disorders .
: Covers emerging areas such as the gastrointestinal and hepatic manifestations of COVID-19 , and a dedicated section on neoplasia involving multiple organs .
: Features more than 1,100 full-color illustrations and quick-reference algorithms to streamline clinical decision-making.
This edition welcomes a new senior editorial team—Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox—and introduces significant updates to reflect the rapidly evolving landscape of GI and hepatology.
Review: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease 12th Edition
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more shop.elsevier.comhttps://shop.elsevier.com
For over 50 years, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease has been the gold standard for medical professionals in the field. The newly released continues this legacy, offering a comprehensive, two-volume masterwork that covers the latest advancements in pathophysiology, diagnosis, and patient management. Key Features of the 12th Edition
: Includes expanded discussions on using Artificial Intelligence (AI) in endoscopy for improved cancer detection.
: Provides the latest evidence-based guidance on metabolic dysfunction-associated steatotic liver disease ( MASLD ), eosinophilic disorders, and new treatments for viral hepatitis and inflammatory bowel disorders .